176 related articles for article (PubMed ID: 22082152)
21. Variable response of CNS hemangioblastomas to Pazopanib in a single patient with von Hippel-Lindau disease: Case report.
Taylor DG; Ilyas A; Mehta GU; Chen CJ; Schiff D; Oldfield EH; Asthagiri AR
J Clin Neurosci; 2018 Apr; 50():154-156. PubMed ID: 29396065
[TBL] [Abstract][Full Text] [Related]
22. Molecular pathology and CXCR4 expression in surgically excised retinal hemangioblastomas associated with von Hippel-Lindau disease.
Liang X; Shen D; Huang Y; Yin C; Bojanowski CM; Zhuang Z; Chan CC
Ophthalmology; 2007 Jan; 114(1):147-56. PubMed ID: 17070589
[TBL] [Abstract][Full Text] [Related]
23. Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.
Wotschofsky Z; Liep J; Meyer HA; Jung M; Wagner I; Disch AC; Schaser KD; Melcher I; Kilic E; Busch J; Weikert S; Miller K; Erbersdobler A; Mollenkopf HJ; Jung K
Int J Biol Sci; 2012; 8(10):1363-74. PubMed ID: 23139634
[TBL] [Abstract][Full Text] [Related]
24. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
[TBL] [Abstract][Full Text] [Related]
25. Novel and recurrent germline mutations in the VHL gene in 5 Arab patients with Von Hippel-Lindau disease.
Faiyaz-Ul-Haque M; Jamil M; Aslam M; Abalkhail H; Al-Dayel F; Basit S; Nawaz Z; Zaidi SHE
Cancer Genet; 2020 May; 243():1-6. PubMed ID: 32179488
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of miR-630 in clear cell renal cell carcinoma is associated with lower overall survival.
Zhao JJ; Chen PJ; Duan RQ; Li KJ; Wang YZ; Li Y
Int J Clin Exp Pathol; 2014; 7(6):3318-23. PubMed ID: 25031755
[TBL] [Abstract][Full Text] [Related]
27. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
Krieg M; Marti HH; Plate KH
Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
[TBL] [Abstract][Full Text] [Related]
28. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
Hoang MP; Amirkhan RH
Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
[TBL] [Abstract][Full Text] [Related]
29. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
30. miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.
Chen X; Wang X; Ruan A; Han W; Zhao Y; Lu X; Xiao P; Shi H; Wang R; Chen L; Chen S; Du Q; Yang H; Zhang X
Clin Cancer Res; 2014 May; 20(10):2617-30. PubMed ID: 24647573
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
[TBL] [Abstract][Full Text] [Related]
32. miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.
Butz H; Szabó PM; Khella HW; Nofech-Mozes R; Patocs A; Yousef GM
Oncotarget; 2015 May; 6(14):12543-57. PubMed ID: 26002553
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
Miyagami M; Katayama Y; Nakamura S
Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
[TBL] [Abstract][Full Text] [Related]
34. Down-regulation of miR-497 is associated with poor prognosis in renal cancer.
Zhao X; Zhao Z; Xu W; Hou J; Du X
Int J Clin Exp Pathol; 2015; 8(1):758-64. PubMed ID: 25755771
[TBL] [Abstract][Full Text] [Related]
35. von Hippel-Lindau disease-associated hemangioblastomas are derived from embryologic multipotent cells.
Park DM; Zhuang Z; Chen L; Szerlip N; Maric I; Li J; Sohn T; Kim SH; Lubensky IA; Vortmeyer AO; Rodgers GP; Oldfield EH; Lonser RR
PLoS Med; 2007 Feb; 4(2):e60. PubMed ID: 17298169
[TBL] [Abstract][Full Text] [Related]
36. [Clinicopathological analysis of clear cell renal cell carcinoma with hemangioblastoma component].
Huang HJ; Chen MJ; Li XO; Zhong DR
Zhonghua Bing Li Xue Za Zhi; 2021 Feb; 50(2):103-107. PubMed ID: 33535303
[No Abstract] [Full Text] [Related]
37. Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.
Liep J; Kilic E; Meyer HA; Busch J; Jung K; Rabien A
PLoS One; 2016; 11(6):e0157801. PubMed ID: 27336447
[TBL] [Abstract][Full Text] [Related]
38. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
[TBL] [Abstract][Full Text] [Related]
39. A Case of von Hippel-Lindau Disease with Colorectal Adenocarcinoma, Renal Cell Carcinoma and Hemangioblastomas.
Heo SJ; Lee CK; Hahn KY; Kim G; Hur H; Choi SH; Han KS; Cho A; Jung M
Cancer Res Treat; 2016 Jan; 48(1):409-14. PubMed ID: 25715769
[TBL] [Abstract][Full Text] [Related]
40. A 41-year-old woman with von Hippel-Lindau and a cerebellar lesion.
Martin SE; Al-Khatib SM; Turner MS; Douglas-Akinwande AC; Hattab EM
Brain Pathol; 2010 Mar; 20(2):511-4. PubMed ID: 20438472
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
